首页> 外文期刊>International journal of hematology >Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administration
【24h】

Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administration

机译:在胸腺切除术和环孢菌素施用后完全缓解纯白细胞增生与胸腺瘤相关的纯白色细胞凋亡

获取原文
获取原文并翻译 | 示例
           

摘要

We present the case of a 63-year-old male with pure white cell aplasia (PWCA), a rare complication of thymoma, who was successfully treated with cyclosporine A (CyA) and thymectomy. The patient presented with high fever and agranulocytosis. Complete blood count revealed a white blood cell count of 0.9x10(9)/L (3% neutrophils), a hemoglobin level of 15.8g/dL, and a platelet count of 308x10(9)/L. Bone marrow (BM) aspiration revealed a hypocellular marrow lacking granulocytes. Computed tomography showed a large anterior mediastinal mass, and the patient was diagnosed with PWCA associated with thymoma. Thirteen days after the initiation of CyA treatment, myeloid cells appeared in the BM, and the neutrophil count in peripheral blood started to increase on day 18. Thymectomy was performed 3months later. Although CyA treatment was discontinued after thymectomy, complete remission has been maintained for over 4years. In vitro colony-forming unit granulocyte-macrophage (CFU-GM) assay using the patient's serum showed severe suppression of CFU-GM colonies in the presence of the patient's serum, suggesting the presence of CFU-GM inhibitor in the patient's serum. The efficacy of the immunosuppressive therapy and the CFU-GM assay suggests the potential involvement of an immunological mechanism in patients with thymoma-associated PWCA.
机译:我们展示了一个63岁的男性,纯白色细胞Aplasia(PWCA),胸腺瘤的罕见并发症,用环孢菌素A(Cya)和胸膜切除术成功处理。患者呈现出高烧和农血细胞症。完全血型揭示了0.9×10(9)/ L(3%中性粒细胞)的白细胞计数,血红蛋白水平为15.8g / d1,血小板计数为308x10(9)/ l。骨髓(BM)展示揭示了缺乏粒细胞的细胞骨髓。计算机断层摄影显示出大的前纵隔物质,患者被诊断为与胸腺瘤相关的PWCA。 13天在启动Cya治疗后,骨髓细胞出现在BM中,并且在18天开始血液血液中的嗜中性粒细胞计数。胸膜切除术后进行3个月。虽然在胸腺切除术后停止了CYA治疗,但已经过4年的完全缓解。使用患者血清的体外菌落形成单位粒细胞 - 巨噬细胞(CFU-GM)测定在患者血清存在下表现出CFU-GM菌落的严重抑制,表明患者血清中的CFU-GM抑制剂存在。免疫抑制治疗和CFU-GM测定的功效表明免疫机制在胸腺瘤相关的PWCA患者中的潜在累及。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号